| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 270.14 mm | 270.14 mm | 270.14 mm | 270.14 mm | 270.14 mm | 270.14 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 8.31 mm | 8.33 mm | 5.49 mm | 6.23 mm |
| Cash used (since last report) | n/a | n/a | 42.09 mm | 42.18 mm | 27.77 mm | 31.54 mm |
| Cash remaining | n/a | n/a | 228.05 mm | 227.95 mm | 242.37 mm | 238.60 mm |
| Runway (months of cash) | n/a | n/a | 27.4 | 27.4 | 44.2 | 38.3 |
| 13F holders | Current |
|---|---|
| Total holders | 164 |
| Opened positions | 37 |
| Closed positions | 36 |
| Increased positions | 68 |
| Reduced positions | 33 |
| 13F shares | Current |
|---|---|
| Total value | 464.38 bn |
| Total shares | 112.19 mm |
| Total puts | 119.00 k |
| Total calls | 473.10 k |
| Total put/call ratio | 0.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Soleus Capital Management | 8.14 mm | $45.11 bn |
| Soleus Capital Master Fund | 8.14 mm | $37.78 mm |
| Orbimed Advisors | 7.56 mm | $41.90 bn |
| Vivo Capital | 6.90 mm | $38.20 bn |
| BlackRock | 5.74 mm | $31.82 bn |
| Deep Track Capital | 5.58 mm | $30.89 bn |
| Schonfeld Strategic Advisors | 4.75 mm | $26.32 bn |
| Vivo Capital Fund VIII | 4.60 mm | $31.68 mm |
| Vivo Capital VIII | 4.34 mm | $0.00 |
| Vanguard | 3.87 mm | $21.44 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Feb 25 | Andrew Gengos | Stock Option Common Stock | Grant | Acquire A | No | No | 3.73 | 750,000 | 2.80 mm | 750,000 |
| 20 Feb 25 | Azelby Robert | Stock Option Common Stock | Grant | Acquire A | No | No | 4.13 | 90,000 | 371.70 k | 90,000 |
| 1 Feb 25 | David A Fellows | Stock Option Common Stock | Grant | Acquire A | No | No | 4.46 | 18,650 | 83.18 k | 18,650 |
